• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk Factors Associated with the Activity and Severity of Graves' Ophthalmopathy among Patients at the University of the Philippines Manila-Philippine General Hospital.菲律宾大学马尼拉分校-菲律宾总医院患者中与格雷夫斯眼病活动度和严重程度相关的危险因素
J ASEAN Fed Endocr Soc. 2017;32(2):151-157. doi: 10.15605/jafes.032.02.09. Epub 2017 Sep 7.
2
Clinical Implications of Immunoglobulin G4 to Graves' Ophthalmopathy.免疫球蛋白 G4 与格雷夫斯眼病的临床意义。
Thyroid. 2017 Sep;27(9):1185-1193. doi: 10.1089/thy.2017.0126.
3
TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patients.采用第三代检测方法测定的促甲状腺激素受体抗体滴度,不能反映未经治疗的日本格雷夫斯病患者格雷夫斯眼病的活动情况。
Endocr J. 2016;63(2):151-7. doi: 10.1507/endocrj.EJ15-0137. Epub 2015 Nov 18.
4
Factors associated with severity of orbitopathy in patients with Graves' disease.格雷夫斯病患者眼眶病严重程度的相关因素。
Taiwan J Ophthalmol. 2020 May 4;10(3):197-202. doi: 10.4103/tjo.tjo_10_20. eCollection 2020 Jul-Sep.
5
A retrospective study of clinical features and prognosis of patients with Graves' disease and ophthalmopathy.格雷夫斯病合并眼病患者临床特征及预后的回顾性研究
Nucl Med Commun. 2023 Feb 1;44(2):137-141. doi: 10.1097/MNM.0000000000001649. Epub 2022 Dec 16.
6
THYROTROPIN-RECEPTOR ANTIBODIES, IMMUNOGLOBULIN E AND ANTINUCLEAR ANTIBODIES IN PATIENTS WITH GRAVES' DISEASE AND GRAVES' ORBITOPATHY.格雷夫斯病和格雷夫斯眼眶病患者的促甲状腺素受体抗体、免疫球蛋白E和抗核抗体
Acta Endocrinol (Buchar). 2021 Apr-Jun;17(2):194-199. doi: 10.4183/aeb.2021.194.
7
CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy.CD4 + T细胞和Th1/Th2失衡与格雷夫斯眼病的发病机制有关。
Int J Mol Med. 2006 May;17(5):911-6.
8
Nicotinamide phosphoribosyltransferase leukocyte overexpression in Graves' opthalmopathy.烟酰胺磷酸核糖基转移酶在Graves眼病患者白细胞中的过表达
Endocrine. 2016 Aug;53(2):497-504. doi: 10.1007/s12020-015-0855-8. Epub 2016 Jan 14.
9
Increased TRAb and/or low anti-TPO titers at diagnosis of graves' disease are associated with an increased risk of developing ophthalmopathy after onset.格雷夫斯病诊断时促甲状腺素受体抗体升高和/或抗甲状腺过氧化物酶滴度降低与发病后发生眼病的风险增加相关。
Exp Clin Endocrinol Diabetes. 2014 Feb;122(2):113-7. doi: 10.1055/s-0033-1363193. Epub 2014 Feb 19.
10
Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves' ophthalmopathy receiving corticosteroid therapy.接受皮质类固醇治疗的格雷夫斯眼病患者眼部自身免疫某些标志物的纵向行为与眼部检查结果变化之间的关系。
Clin Endocrinol (Oxf). 2003 Sep;59(3):388-95. doi: 10.1046/j.1365-2265.2003.01861.x.

引用本文的文献

1
Prediction of exophthalmos by body mass index for craniofacial reconstruction: consequences for cold cases.利用身体质量指数预测颅面重建术后眼球突出:对冷案的影响。
Forensic Sci Med Pathol. 2024 Jun;20(2):335-350. doi: 10.1007/s12024-023-00649-8. Epub 2023 Jun 7.
2
Assessment of the levels of interleukin-17 and interleukin-38 in thyroid-associated ophthalmopathy patients.评估甲状腺相关眼病患者白细胞介素-17 和白细胞介素-38 的水平。
Int Ophthalmol. 2023 Aug;43(8):2811-2824. doi: 10.1007/s10792-023-02679-1. Epub 2023 Mar 9.
3
Epidemiological Status of Thyroid Eye Disease in Central Iran.伊朗中部甲状腺眼病的流行病学状况
J Curr Ophthalmol. 2022 Apr 16;34(1):106-111. doi: 10.4103/joco.joco_223_21. eCollection 2022 Jan-Mar.
4
Factors associated with severity of orbitopathy in patients with Graves' disease.格雷夫斯病患者眼眶病严重程度的相关因素。
Taiwan J Ophthalmol. 2020 May 4;10(3):197-202. doi: 10.4103/tjo.tjo_10_20. eCollection 2020 Jul-Sep.

本文引用的文献

1
Building the Case for Insulin-Like Growth Factor Receptor-I Involvement in Thyroid-Associated Ophthalmopathy.论证胰岛素样生长因子受体-I参与甲状腺相关眼病
Front Endocrinol (Lausanne). 2017 Jan 3;7:167. doi: 10.3389/fendo.2016.00167. eCollection 2016.
2
Diagnosis, Follow-Up and Treatment Results in Thyroid Ophthalmopathy.甲状腺眼病的诊断、随访及治疗结果
Turk J Ophthalmol. 2015 Aug;45(4):156-163. doi: 10.4274/tjo.93609. Epub 2015 Aug 5.
3
The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy.2016年欧洲甲状腺协会/欧洲Graves眼病研究组Graves眼病管理指南
Eur Thyroid J. 2016 Mar;5(1):9-26. doi: 10.1159/000443828. Epub 2016 Mar 2.
4
Risk Factors for Graves' Orbitopathy; the Australian Thyroid-Associated Orbitopathy Research (ATOR) Study.格雷夫斯眼病的风险因素;澳大利亚甲状腺相关眼病研究(ATOR)。
J Clin Endocrinol Metab. 2016 Jul;101(7):2711-20. doi: 10.1210/jc.2015-4294. Epub 2016 Apr 7.
5
THERAPY OF ENDOCRINE DISEASE: Endocrine dilemma: management of Graves' orbitopathy.内分泌疾病的治疗:内分泌难题:格雷夫斯眼眶病的管理
Eur J Endocrinol. 2016 Sep;175(3):R117-33. doi: 10.1530/EJE-15-1164. Epub 2016 Mar 31.
6
TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patients.采用第三代检测方法测定的促甲状腺激素受体抗体滴度,不能反映未经治疗的日本格雷夫斯病患者格雷夫斯眼病的活动情况。
Endocr J. 2016;63(2):151-7. doi: 10.1507/endocrj.EJ15-0137. Epub 2015 Nov 18.
7
Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.格雷夫斯眼眶病慢性非活动期促甲状腺激素受体抗体水平与疾病严重程度的临床关联
Korean J Ophthalmol. 2015 Aug;29(4):213-9. doi: 10.3341/kjo.2015.29.4.213. Epub 2015 Jul 21.
8
TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy.表达促甲状腺激素受体的纤维细胞与甲状腺相关眼病
Nat Rev Endocrinol. 2015 Mar;11(3):171-81. doi: 10.1038/nrendo.2014.226. Epub 2015 Jan 6.
9
Thyroid eye disease: a Southeast Asian experience.甲状腺眼病:东南亚地区的经验
Br J Ophthalmol. 2015 Apr;99(4):512-8. doi: 10.1136/bjophthalmol-2014-305649. Epub 2014 Oct 31.
10
Prevalence and natural history of Graves' orbitopathy in the XXI century.二十一世纪格雷夫斯眼病的流行率和自然病程。
J Endocrinol Invest. 2013 Jun;36(6):444-9. doi: 10.3275/8937. Epub 2013 Apr 16.

菲律宾大学马尼拉分校-菲律宾总医院患者中与格雷夫斯眼病活动度和严重程度相关的危险因素

Risk Factors Associated with the Activity and Severity of Graves' Ophthalmopathy among Patients at the University of the Philippines Manila-Philippine General Hospital.

作者信息

Lat Annabelle Marie, Jauculan Maria Cristina, Sanchez Charisse Ann, Jimeno Cecilia, Sison-Peña Cherrie Mae, Pe-Yan Mary Rose, Pagkatipunan Paulo Ma, Suller Armida, Cena Marianne

机构信息

Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of the Philippines Manila-Philippine General Hospital.

Section of Plastic-Lacrimal and Orbit, Department of Ophthalmology and Visual Sciences, University of the Philippines Manila-Philippine General Hospital.

出版信息

J ASEAN Fed Endocr Soc. 2017;32(2):151-157. doi: 10.15605/jafes.032.02.09. Epub 2017 Sep 7.

DOI:10.15605/jafes.032.02.09
PMID:33442099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7784205/
Abstract

BACKGROUND

Asians with Graves' ophthalmopathy (GO) may have earlier compressive features due to narrower orbital apex and increased orbital volume.

OBJECTIVE

To determine the risk factors associated with activity and severity of GO among adults.

METHODOLOGY

This was a cross-sectional analytical study of 163 adults with Graves' disease (GD) from the outpatient clinics of the Philippine General Hospital. Demographics, clinical data, thyrotropin receptor antibody (TRAb) and urine iodine (UIE) levels were obtained. All participants were evaluated for activity and severity of GO by a single ophthalmologist.

RESULTS

The population was predominantly composed of females (81%) and nonsmokers (69%), with a mean age of 35 + 11 years and median GD duration of 2 years. Median TRAb was 8.9 U/L while UIE was 171 mcg/L. Eight percent exhibited active GO, with 85% having mild disease. Multivariate analysis showed male sex to be associated with severe disease (OR 3.71, =0.041), while elevated TRAb was associated with both active (OR 1.03, =0.002) and severe GO (OR 1.02, =0.007).

CONCLUSION

Lower rates of active and severe GO were seen compared to previous reports. In this population of predominantly nonsmokers, elevated TRAb emerged as a risk factor for active and severe GO.

摘要

背景

患有格雷夫斯眼病(GO)的亚洲人可能因眶尖较窄和眶容积增加而更早出现压迫症状。

目的

确定成年人中与GO活动度和严重程度相关的危险因素。

方法

这是一项对菲律宾总医院门诊的163例格雷夫斯病(GD)成年患者进行的横断面分析研究。收集了人口统计学、临床数据、促甲状腺素受体抗体(TRAb)和尿碘(UIE)水平。所有参与者均由一名眼科医生评估GO的活动度和严重程度。

结果

研究人群主要为女性(81%)和非吸烟者(69%),平均年龄为35±11岁,GD病程中位数为2年。TRAb中位数为8.9 U/L,UIE为171 mcg/L。8%的患者表现为活动性GO,其中85%为轻度疾病。多变量分析显示男性与严重疾病相关(OR 3.71,P=0.041),而TRAb升高与活动性GO(OR 1.03,P=0.002)和严重GO(OR 1.02,P=0.007)均相关。

结论

与既往报告相比,活动性和严重GO的发生率较低。在这个以非吸烟者为主的人群中,TRAb升高是活动性和严重GO的一个危险因素。